Emission control system utilizing chlorine dioxide and hydrogen peroxide

Details for Australian Patent Application No. 2006315712 (hide)

Owner United States of America, as represented by The Administrator of the National Aeronautics and Space Administration

Inventors Chung, Landy; Parrish, Clyde F.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006315712

PCT Pub. Number WO2007/058936

Priority 11/466,624 23.08.06 US; 60/737,015 14.11.05 US

Filing date 9 November 2006

Wipo publication date 24 May 2007

International Classifications

B01D 53/50 (2006.01) Separation of gases or vapours - Sulfur oxides

B01D 53/54 (2006.01) Separation of gases or vapours - Nitrogen compounds

B01D 53/56 (2006.01) Separation of gases or vapours - Nitrogen oxides

B01D 53/60 (2006.01) Separation of gases or vapours - Simultaneously removing sulfur oxides and nitrogen oxides

B01D 53/78 (2006.01) Separation of gases or vapours - with gas-liquid contact

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/058936 Priority application(s): WO2007/058936

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315715-Identification of USA300 community-associated methicillin-resistant staphylococcus aureus

2006315706-Human G protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto